22 related articles for article (PubMed ID: 2290158)
1. Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.
Fardoun MM; Nassif J; Issa K; Baydoun E; Eid AH
Front Pharmacol; 2016; 7():438. PubMed ID: 27899893
[TBL] [Abstract][Full Text] [Related]
2. Anti-"dividing cell antigen" autoantibody: a novel antinuclear antibody pattern related to histones in systemic lupus erythematosus.
Blaschek M; Muller S; Youinou P
J Clin Immunol; 1993 Sep; 13(5):329-38. PubMed ID: 8245179
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
4. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
5. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
6. Frequency and clinical significance of anti-RNP antibodies in Italian SLE patients.
Montecucco C; Caporali R; Ravelli A; Ronchetti A; Rossi S; Martini A; Notario A
Ann Ital Med Int; 1994; 9(1):12-5. PubMed ID: 8003386
[TBL] [Abstract][Full Text] [Related]
7. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon in mixed connective tissue disease.
Grader-Beck T; Wigley FM
Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
[TBL] [Abstract][Full Text] [Related]
9. [Raynaud's phenomenon and connective tissue diseases].
Guilmot JL; Diot E; Lasfargues G; Boissier C
Rev Prat; 1998 Oct; 48(15):1647-52. PubMed ID: 9814065
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of several connective tissue diseases with anti-Golgi antibody.
Yang Y; Fujita J; Tokuda M; Bandoh S; Ishida T; Murota M; Wu F; Nishioka M
Ann Rheum Dis; 2001 Oct; 60(10):986-7. PubMed ID: 11589180
[No Abstract] [Full Text] [Related]
11. Serological arguments for classifying Raynaud's phenomenon as idiopathic.
Gentric A; Blaschek MA; Le Noach JF; Johanet C; Jouquan J; Lamour A; Abuaf N; Pennec YL; Youinou P
J Rheumatol; 1990 Sep; 17(9):1177-81. PubMed ID: 2290158
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
